3X Genetics develops a diagnostic testing platform for genetic repeat expansion (GRE) diseases, utilizing saliva samples analyzed in a CLIA-certified lab to deliver results within eight weeks. The company addresses the challenge of misdiagnosis in GRE diseases, such as Myotonic Dystrophy and Huntington’s Disease, by providing accurate, low-cost testing and health guidance for patients and their families.
Funding
Funding not disclosed
Founders
Product
Problem
Genetic repeat expansion (GRE) diseases are frequently misdiagnosed due to overlapping symptoms and the complexity of genetic testing. This diagnostic delay can prevent timely access to emerging therapeutics and appropriate health guidance for patients and their families.
Solution
3X Genetics offers diagnostic services for GRE diseases, addressing the challenge of misdiagnosis through accurate and accessible testing. Patients receive a test kit to collect a saliva sample, which is then sent to 3X Genetic’s CLIA-certified lab for analysis. The company's initial service focuses on Myotonic Dystrophy (DM1), with plans to expand to other GRE diseases such as Fuchs Endothelial Corneal Dystrophy (FECD), Friedreich’s Ataxia (FA), Fragile X Syndrome (FXS), Huntington’s Disease and spinocerebellar ataxias (SCAs). Test results indicating the need for further evaluation are delivered by a Genetic Counselor.
Target Audience
The primary target audience includes individuals suspected of having a GRE disease, their families, and medical professionals seeking accurate diagnostic tools for these conditions.
Features
- Saliva-based diagnostic testing for genetic repeat expansion diseases
- CLIA-certified genetic testing lab ensures accuracy and reliability
- Focus on Myotonic Dystrophy (DM1) testing initially, with plans to expand to other GRE diseases
- Results delivered within eight weeks of sample receipt
- Genetic Counselor provides results and guidance for cases requiring further evaluation
- Free testing for family members of verified GRE patients, sponsored by 3X Genetics
- Secure data handling with patient-owned and encrypted test results